Heart failure and angiotensin II modulate atrial Pitx2c promotor methylation

Clinical and Experimental Pharmacology and Physiology

Volumn 40, Issue 6, 2013, Pages 379-384

  Kao, Yu Hsun ^a,b   Chen, Yao Chang ^c   Chung, Chen Chih ^a,b   Lien, Gi Shih ^a   Chen, Shih Ann ^d,e   Kuo, Ching Chuan ^f   Chen, Yi Jen ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f Nation Health Research Institute   (Taiwan)

Author keywords

Angiotensin II; Atrial fibrillation; Epigenetics; Heart failure; Pitx2c

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANGIOTENSIN II; DNA METHYLTRANSFERASE 1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; ISOPRENALINE; LOSARTAN; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION; HEART FAILURE; HEART LEFT ATRIUM; HOMEOBOX; IMMUNOBLOTTING; MALE; NONHUMAN; PITX2C GENE; PROMOTER REGION; PROTEIN EXPRESSION; PYROSEQUENCING; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; AZACITIDINE; CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DRUG INTERACTIONS; ENZYME INHIBITORS; HEART ATRIA; HEART FAILURE; HOMEODOMAIN PROTEINS; ISOPROTERENOL; LOSARTAN; MALE; PROMOTER REGIONS, GENETIC; RATS; RNA; TRANSCRIPTION FACTORS;

EID: 84878389670     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12089     Document Type: Article

References (28)

1. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation. N. Engl. J. Med. 1982; 306: 1018-22.
2. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: Epidemiology, pathophysiology, and rationale for therapy. Am. J. Cardiol. 2003; 91: 2-8.
3. Lin YK, Chen YC, Chen JH, Chen SA, Chen YJ. Adipocytes modulate the electrophysiology of atrial myocytes: Implications in obesity-induced atrial fibrillation. Basic Res. Cardiol. 2012; 107: 293.
4. Suenari K, Chen YC, Kao YH et al. Discrepant electrophysiological characteristics and calcium homeostasis of left atrial anterior and posterior myocytes. Basic Res. Cardiol. 2011; 106: 65-74.
5. Chen YJ, Chen YC, Tai CT, Yeh HI, Lin CI, Chen SA. Angiotensin II and angiotensin II receptor blocker modulate the arrhythmogenic activity of pulmonary veins. Br. J. Pharmacol. 2006; 147: 12-22.
6. Gudbjartsson DF, Arnar DO, Helgadottir A et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007; 448: 353-7.
7. Cheng CC, Pan NH, Chen YC et al. Atherosclerosis modulates the electrophysiological effects of a peroxisome proliferator-activated receptor-gamma activator on pulmonary veins. Int. J. Cardiol. 2010; 145: 578-82.
8. Liu C, Liu W, Lu M-F, Brown NA, Martin JF. Regulation of left-right asymmetry by thresholds of Pitx2c activity. Development 2001; 128: 2039-48.
9. Bamforth SD, Braganca J, Farthing CR et al. Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway. Nat. Genet. 2004; 36: 1189-96.
10. Hamada H, Meno C, Watanabe D, Saijoh Y. Establishment of vertebrate left-right asymmetry. Nat. Rev. Genet. 2002; 3: 103-13.
11. Mommersteeg MTM, Brown NA, Prall OWJ et al. Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ. Res. 2007; 101: 902-9.
12. Kirchhof P, Kahr PC, Kaese S et al. Pitx2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression. Circ. Cardiovasc. Genet. 2011; 4: 123-33.
13. Chinchilla A, Daimi H, Lozano-Velasco E et al. Pitx2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. Circ. Cardiovasc. Genet. 2011; 4: 269-79.
14. Maier S, Nimmrich I, Koenig T et al. DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients: Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group. Eur. J. Cancer 2007; 43: 1679-86.
15. Weiss G, Cottrell S, Distler J et al. DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy. J. Urol. 2009; 181: 1678-85.
16. Lin YK, Chen YC, Chang SL et al. Heart failure epicardial fat increases atrial arrhythmogenesis. Int. J. Cardiol. 2012; Epub 25 May 2012; doi:10.1016/j.ijcard.2012.05.009
17. 2+-ATPase and calcium homeostasis in cardiac myocytes. Lab. Invest. 2011; 91: 1291-7.
18. 2+-ATPase expressions via the promoter methylation in cardiomyocytes. Crit. Care Med. 2010; 38: 217-22.
19. Kox M, Pickkers P. Poison to the heart. Crit. Care Med. 2010; 38: 331-2.
20. Zablocki D, Sadoshima J. The one-two punch: Knocking out angiotensin II in the heart. J. Clin. Invest. 2010; 120: 1028-31.
21. Unger T, Li J. The role of the renin-angiotensin-aldosterone system in heart failure. J. Renin Angiotensin Aldosterone Syst. 2004; 5(Suppl. 1): S7-10.
22. White SM, Constantin PE, Claycomb WC. Cardiac physiology at the cellular level. Use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am. J. Physiol. Heart Circ. Physiol. 2004; 286: H823-9.
23. Wang J, Klysik E, Sood S, Johnson RL, Wehrens XHT, Martin JF. Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification. Proc. Natl Acad. Sci. USA 2010; 107: 9753-8.
24. Mommersteeg MTM, Hoogaars WMH, Prall OWJ et al. Molecular pathway for the localized formation of the sinoatrial node. Circ. Res. 2007; 100: 354-62.
25. Yang B, Lin H, Xiao J et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 2007; 13: 486-91.
26. Schneider MP, Hua TA, Bohm M, Wachtell K, Kjeldsen SE, Schmieder RE. Prevention of atrial fibrillation by renin-angiotensin system inhibition: A meta-analysis. J. Am. Coll. Cardiol. 2010; 55: 2299-307.
27. Bacanamwo AM, Wang D, Gibbons GH. Inhibition of DNA methyltransferase inhibits the Ang II-induced increase in blood pressure, vascular remodeling and target organ damage. Circulation 2007; 116(Suppl. II): II-124 (Abstract).
28. Bestor TH, The DNA. methyltransferases of mammals. Hum. Mol. Genet. 2000; 9: 2395-402.